Literature DB >> 10147004

The economics of screening for measles.

J A Sellick.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 10147004     DOI： 10.2165/00019053-199202060-00003

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  13 in total

1.  Measles--United States, 1990.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1991-06-07       Impact factor: 17.586

2.  Risk factors for measles in a previously vaccinated population and cost-effectiveness of revaccination strategies.

Authors:  E E Mast; J L Berg; L P Hanrahan; J T Wassell; J P Davis
Journal:  JAMA       Date:  1990-11-21       Impact factor: 56.272

Review 3.  Prevention of mumps, measles, and rubella among hospital personnel.

Authors:  D J Weber; W A Rutala; W A Orenstein
Journal:  J Pediatr       Date:  1991-08       Impact factor: 4.406

4.  Prevaccination serologic screening for measles in health care workers.

Authors:  E K Subbarao; S Amin; M L Kumar
Journal:  J Infect Dis       Date:  1991-04       Impact factor: 5.226

5.  Cost-effectiveness evaluation of measles immunization strategies on a college campus.

Authors:  D M Shlian; D Matchar; G B Seymann
Journal:  Fam Pract Res J       Date:  1991-06

6.  Serologic screening, mass immunization, and implications for immunization programs.

Authors:  M Grabowsky; L Markowitz
Journal:  J Infect Dis       Date:  1991-12       Impact factor: 5.226

7.  Measles--United States, 1988.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  1989-09-08       Impact factor: 17.586

8.  Screening hospital employees for measles immunity is more cost effective than blind immunization.

Authors:  J A Sellick; D Longbine; R Schifeling; J M Mylotte
Journal:  Ann Intern Med       Date:  1992-06-15       Impact factor: 25.391

9.  Health impact of measles vaccination in the United States.

Authors:  A B Bloch; W A Orenstein; H C Stetler; S G Wassilak; R W Amler; K J Bart; C D Kirby; A R Hinman
Journal:  Pediatrics       Date:  1985-10       Impact factor: 7.124

10.  Benefits, risks and costs of immunization for measles, mumps and rubella.

Authors:  C C White; J P Koplan; W A Orenstein
Journal:  Am J Public Health       Date:  1985-07       Impact factor: 9.308
View more
  1 in total

Review 1.  Pharmacoeconomics of immunisation: a review.

Authors:  R van den Oever; D de Graeve; B Hepp; A Stroobant; D Walckiers; V Van Casteren; F Van Loock; G Ducoffre; J Dewatripont; P Jacques
Journal:  Pharmacoeconomics       Date:  1993-04       Impact factor: 4.981
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.